Background {#Sec1}
==========

Coronary artery disease (CAD), which consists of clinical manifestations including stable or unstable angina, myocardial infarction, and sudden coronary death, is a leading cause of disability and death worldwide \[[@CR1], [@CR2]\]. The prevalence of CAD is reported to be 4.6--9.2% in the overall population, and 11.3--31.3% among the elderly aged over 65 \[[@CR3]\]. Due to its high prevalence and incapacity, CAD has become a major health concern and imposed a heavy burden on society \[[@CR2], [@CR4]\].

A range of environmental factors like smoking \[[@CR5]\], unhealthy diet and lifestyle \[[@CR6]\], lack of physical activity \[[@CR7]\], and low socioeconomic status \[[@CR8]\], have been reported to stimulate the occurrence and progression of CAD. The large majority of CAD, nevertheless, are multifactorial with both environmental and heritable contributions \[[@CR9]\]. Familial aggregation of CAD has been observed for a long time, and overwhelming evidence indicated the genetic predisposition to CAD \[[@CR10], [@CR11]\]. Twin studies revealed the heritability estimates for CAD ranged from 41 to 77% \[[@CR12]\]. The importance of genetic factors in CAD resulted in extensive identification of considerable candidate genes and numerous single-nucleotide polymorphisms (SNPs) that were related to this condition \[[@CR13]\].

Nuclear factor-κB (NF-κB) is a cluster of ubiquitous transcription factors. In the NF-κB family, there are five members including NF-κB1, RelA, c-Rel, RelB, and NF-κB2. As a fundamental transcription regulator, NF-κB participates in most biological processes. The NF-κB signaling pathway also plays a crucial role in heart diseases \[[@CR14]\]. NF-κB1 is encoded by *NF-κB1* gene, which is mapped to chromosome 4q24. *Rs28362491* polymorphism is a 4 bp ATTG insertion/deletion variation in -94 bp of *NF-κB1* promoter. This polymorphic site was reported to have great impact on the expression of *NF-κB1* gene, with the deletion of ATTG causing reduced promoter activity.

Xie et al. \[[@CR15]\] initially reported the correlation between *rs28362491* polymorphism and risk of CAD in a Chinese cohort, investigators attempted to conduct replicate studies in different populations with inconsistent results. The conflicting findings might ascribe to small sample size and weak statistical power of an individual study. Therefore, we carried out this meta-analysis to obtain more convincing evidence on the association of *rs28362491* polymorphism and CAD susceptibility.

Methods {#Sec2}
=======

Search strategy of literature {#Sec3}
-----------------------------

We searched databases of Web of Science, EMBASE, PubMed, Wanfang, and CNKI before August 1, 2019. For PubMed database, the search string was ("Polymorphism, Genetic"\[Mesh\] OR polymorphism OR Single Nucleotide Polymorphism OR Genetic Polymorphism OR Mutant OR Variant) AND ("NF-kappa B p50 Subunit"\[Mesh\] OR NFKB1 OR NF-kappa B p50 Subunit OR NF-κB1 OR NF-kappa B p50 OR NF kappa B p50) AND (Acute coronary syndrome OR Coronary Artery Disease OR Coronary Arteriosclerosis OR Coronary Atherosclerosis OR "Coronary Artery Disease"\[Mesh\]). No language restriction was set during the literature search process. The reference lists of relevant studies were manually examined to obtain more publications.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

Identified studies met the following criteria were included: (i) case-control or cohort studies investigating *rs28362491* and CAD; (ii) confirmed diagnosis of CAD for cases; (iii) studies with available data to calculate odds ratios (ORs) and 95% confidence intervals (95%CIs); (iv) studies that conformed to Hardy-Weinberg equilibrium (HWE) \[[@CR16]\]. Accordingly, editorial, review, conference abstract, and animal study were excluded.

Quality assessment {#Sec5}
------------------

Quality assessment was carried out by two investigators independently (YW and BW) based upon Newcastle-Ottawa Scale (NOS) \[[@CR17]\]. The quality of each study was judged by three aspects including selection (4 items), comparability (2 items), and exposure (3 items). Scores of 0--3, 4--6, and 7--9 suggested low-, moderate-, and high-quality, respectively.

Data extraction {#Sec6}
---------------

The following data were collected by two investigators independently (YW and BW): (i) first author; (ii) date of publication; (iii) nationality of participants; (iv) ethnicity; (v) gender; (vi) sample size; (vii) genotype distribution; (viii) results of HWE test. Any disagreement was resolved until reaching a consensus.

Statistical analysis {#Sec7}
--------------------

The association of *rs28362491* polymorphism and CAD risk was presented as ORs and 95%CIs in allelic model (D vs. I), homozygous model (DD vs. II), heterozygous model (DI vs. II), dominant model (DD + DI vs. II), and recessive model (DD vs. DI + II). Q-statistical test and I^2^ test were used to examine the between-study heterogeneity. *P* \< 0.1 and I^2^ \> 50% indicated the heterogeneity was considerable, and a random-effects model should be applied, otherwise a fixed-effects model could be employed. Subgroup-analyses by ethnicity and gender were performed to test if there were ethnicity-specific and gender-specific effects. The data analyses were accomplished using RevMan 5.3 software.

Sensitivity analysis and publication bias {#Sec8}
-----------------------------------------

Stability of the pooled results was detected through sensitivity analysis by removing each dataset in turn and recalculating the effect sizes. Publication bias was examined by funnel plots.

Results {#Sec9}
=======

Literature search {#Sec10}
-----------------

Ninety-six items were obtained after the search of five databanks and reference lists of relevant studies. Thirty-nine items were deleted because of duplication. Of the remaining 57 items, 40 obviously irrelevant citations were removed after the screen of titles and abstracts. After that, another four ineligible articles were deleted after comprehensive assessment. Finally, 13 studies with 17 individual cohorts were included in the final meta-analysis. The procedures of literature search and selection were displayed in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Flow chart of literature search and screen

Main characteristics {#Sec11}
--------------------

Main characteristics of the eligible studies were summarized in Table [1](#Tab1){ref-type="table"}. Thirteen studies \[[@CR15], [@CR18]--[@CR29]\] with 17 individual cohorts containing 9378 cases and 10,738 controls were incorporated into this meta-analysis. Of them, 11 studies \[[@CR19]--[@CR29]\] were published in English and the rest two studies \[[@CR15], [@CR18]\] were in Chinese. The studies by Yang et al. \[[@CR26]\], Stegger et al. \[[@CR28]\], and Mishra et al. \[[@CR29]\] consisted of two, three, and two individual cohorts, respectively. The included studies were conducted in different countries including China, Iran, Spain, Turkey, Denmark, USA, and India. Of note, the diagnosis of CAD was through coronary angiography by all included study with the exception of Stegger et al. \[[@CR28]\], in which CAD was defined as unstable angina pectoris, myocardial infarction, and fatal coronary heart disease. All the studies conformed to HWE. In the light of NOS, all eligible studies obtained 5 to 9 stars, indicating a moderate to high quality (Table [2](#Tab2){ref-type="table"}). Table 1Main characteristics of included studiesStudyYearCountryEthnicityGenderSample sizeCaseControlHWEDDDIIIDDDIIIHu XJ2019ChinaAsianBoth182/307368165401471200.63Jin SY2019ChinaAsianBoth778/11121403872511575294260.72Coto E2019SpainCaucasianMale609/42391291227592011630.81Seidi A2018IranAsianBoth124/100275047938530.57Luo JY2017ChinaAsianBoth1184/11122155624071575294260.72Lai HM2015ChinaAsianBoth960/10601784253571314924370.70Lai H2015ChinaAsianBoth1140/11562185303921545614410.24Arslan S2015TurkeyAsianBoth226/20136114762096850.34Mishra A2014IndiaAsianBoth510/2304616629815681470.07Yang YN (I)2014ChinaAsianBoth633/6161262822251032912220.64Yang YN (II)2014ChinaAsianBoth437/35670195172481611470.71Stegger JG (I)2013DenmarkCaucasianBoth1012/17191714843572557926720.39Stegger JG (II)2013USACaucasianMale427/873572161541403893440.09Stegger JG (III)2013USACaucasianFemale471/922752131831484123620.09Mishra A (I)2013IndiaAsianBoth310/230279618715681470.07Mishra A (II)2013IndiaAsianBoth290/230289916315681470.07Xie FY2008ChinaAsianBoth85/881841262241250.53*HWE* Hardy-Weinberg EquilibriumTable 2Quality assessment of included studies according to the Newcastle-Ottawa ScaleItem/StudyAdequate definition of casesRepresentativeness of casesSelection of control subjectsDefinition of control subjectsControl for important factorExposure assessmentSame method of ascertainment for all subjectsNon-response rateTotalHu XJ, 2019 \[[@CR18]\]100111116Jin SY, 2019 \[[@CR19]\]100121117Coto E, 2019 \[[@CR20]\]101111117Seidi A, 2018 \[[@CR21]\]100111116Luo JY, 2017 \[[@CR22]\]100121117Lai HM, 2015 \[[@CR23]\]101121118Lai H, 2015 \[[@CR24]\]101121118Arslan S, 2015 \[[@CR25]\]100121117Yang YN, 2015 \[[@CR26]\]101121118Mishra A, 2013 \[[@CR27]\]100121117Stegger JG, 2013 \[[@CR28]\]111121119Mishra A, 2013 \[[@CR27]\]110121118Xie FY, 2008 \[[@CR15]\]100111116

Meta-analysis and subgroup-analysis {#Sec12}
-----------------------------------

Results of overall and subgroup analyses were summarized in Table [3](#Tab3){ref-type="table"}. For the overall populations, between-study heterogeneity was observed in recessive model, and the random-effects model was employed. For the rest contrasts, little heterogeneity was found and the fixed-effects model was used. The pooled data indicated that *rs28362491* was significantly associated with increased risk of CAD under all five genetic models: D vs. I, OR = 1.16, 95%CI 1.11--1.21, *P*\<0.01 (Fig. [2](#Fig2){ref-type="fig"}); DD vs. II, OR = 1.37, 95%CI 1.25--1.49, *P*\<0.01; DI vs. II, OR = 1.11, 95%CI 1.05--1.18, *P*\<0.01; DD + DI vs. II, OR = 1.17, 95%CI 1.11--1.24, *P*\<0.01; DD vs. DI + II, OR = 1.29, 95%CI 1.15--1.43, *P*\<0.01. Table 3Association between *rs28362491* polymorphism and coronary artery diseaseGenetic modelNo. of cohortsAssociationEffect modelHeterogeneityOR95%CIP-valueI^2^ (%)P-valueOverall D vs. I171.161.11--1.21\<0.01F210.20 DD vs. II171.371.25--1.49\<0.01F320.10 DI vs. II171.111.05--1.18\<0.01F00.95 DD + DI vs. II171.171.11--1.24\<0.01F00.84 DD vs. DI + II171.291.15--1.43\<0.01R380.06Asian D vs. I131.211.15--1.27\<0.01F00.52 DD vs. II131.501.35--1.67\<0.01F00.58 DI vs. II131.111.03--1.20\<0.01F00.90 DD + DI vs. II131.201.12--1.28\<0.01F00.79 DD vs. DI + II131.431.30--1.57\<0.01F00.67Caucasian D vs. I41.070.99--1.150.08F00.58 DD vs. II41.110.95--1.290.20F00.44 DI vs. II41.121.00--1.250.05F00.67 DD + DI vs. II41.121.00--1.240.04F00.72 DD vs. DI + II41.040.90--1.200.59F150.31Female D vs. I81.141.06--1.24\<0.01F140.32 DD vs. II81.371.16--1.61\<0.01F410.11 DI vs. II81.060.94--1.190.36F00.82 DD + DI vs. II81.131.01--1.260.04F00.83 DD vs. DI + II81.371.08--1.73\<0.01R530.04Male D vs. I91.161.05--1.27\<0.01R550.02 DD vs. II91.301.07--1.600.01R590.01 DI vs. II91.181.04--1.34\<0.01R430.08 DD + DI vs. II91.211.07--1.37\<0.01R460.06 DD vs. DI + II91.190.99--1.420.06R570.02*OR* Odds ratio, *CI* Confidence interval, *F* Fixed-effects model, *R* Random-effects modelFig. 2Forest plot of association between *rs28362491* and coronary artery disease in allelic model

Subgroup analysis by ethnicity revealed that *rs28362491* was significantly associated with an increased CAD risk in Asians under five genetic models: D vs. I, OR = 1.21, 95%CI 1.15--1.27, *P*\<0.01; DD vs. II, OR = 1.50, 95%CI 1.35--1.67, *P*\<0.01; DI vs. II, OR = 1.11, 95%CI 1.03--1.20, *P*\<0.01; DD + DI vs. II, OR = 1.20, 95%CI 1.12--1.28, *P*\<0.01; DD vs. DI + II, OR = 1.43, 95%CI 1.30--1.57, *P*\<0.01. While, for the Caucasian population, only marginally positive associations were witnessed in heterozygous model (DI vs. II, OR = 1.12, 95%CI 1.00--1.25, *P* = 0.05) and dominant model (DD + DI vs. II, OR = 1.12, 95%CI 1.00--1.24, *P* = 0.04), and no association was observed under other contrasts.

Further subgroup analysis by gender demonstrated that *rs28362491* was significantly associated with an increased risk of CAD in females under allelic model (D vs. I, OR = 1.14, 95%CI 1.06--1.24, *P*\<0.01), homozygous model (DD vs. II, OR = 1.37, 95%CI 1.16--1.61, *P*\<0.01), dominant model (DD + DI vs. II, OR = 1.13, 95%CI 1.01--1.26, *P* = 0.04), and recessive model (DD vs. DI + II, OR = 1.37, 95%CI 1.08--1.73, *P*\<0.01). When it came to males, significant associations were found under allelic model (D vs. I, OR = 1.16, 95%CI 1.05--1.27, *P*\<0.01), homozygous model (DD vs. II, OR = 1.30, 95%CI 1.07--1.60, *P* = 0.01), heterozygous model (DI vs. II, OR = 1.18, 95%CI 1.04--1.34, *P*\<0.01), and dominant model (DD + DI vs. II, OR = 1.21, 95%CI 1.07--1.37, *P*\<0.01).

Sensitivity analysis and publication bias {#Sec13}
-----------------------------------------

After removal of each study, the re-calculated effect sizes did not reverse, which confirmed the stability and reliability of our findings. Visual inspection of funnel plots did not identify obvious asymmetry, indicating the outcomes were unlikely to have severe publication bias (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Funnel plot of association between *rs28362491* and coronary artery disease

Discussion {#Sec14}
==========

CAD causes nearly one-third of all deaths in individuals aged over 35 \[[@CR30]\]. However, the etiology of CAD remains far from clear. Knowledge of the etiology behind CAD can lead to early preventative modifications and improved therapeutics of this disease. Similar to most diseases, CAD is also a multifactorial disorder. In the past decade, genetic factors were recognized to make substantial contribution to CAD vulnerability and received much more attentions. Genome-wide association studies and case-control studies have recognized considerable genes and polymorphic loci that are associated with CAD risk \[[@CR13], [@CR31]\]. *Rs28362491* polymorphism in *NF-κB1* gene is one of the most widely studied locus.

Studies on the association of *rs28362491* polymorphism and CAD predisposition have been carried out in different regions. However, it is quite regrettable that those studies reported inconsistent findings and more convincing evidence remains to be determined. By merging the data from previous studies, this meta-analysis indicated that *rs28362491* was significantly associated with CAD. The findings of subgroup-analyses witnessed that *rs28362491* was significantly associated with CAD in dominant comparison, regardless of ethnicity and gender. Of note, in the Caucasian population, the association was of borderline significance, which might be attributable to limited sample size of participants. In addition, the trends of associations in different genders were not always consistent, which might be caused by gender differences of genotype distributions.

NF-κB is a pleiotropic transcription regulator implicating in diverse biological process including cell proliferation, differentiation, adhesion, and apoptosis, thus exerting crucial effects on multiple pathological states like inflammatory response, which plays a vital role in the development of CAD \[[@CR32]\]. Despite different dimeric forms of NF-κB have been reported, NF-κB1 and RelA are the most extensively studied isoforms \[[@CR33]\]. *NF-κB1* gene encodes a non-DNA-binding cytoplasmic protein (p105) and a DNA-binding protein (p50) that bind to N-terminus of p105 \[[@CR34]\]. Campbell et al. \[[@CR35]\] reported that p50 homodimers could impede p65 dimers from combining to promoters and activating genes involved in inflammatory response. The p50 homodimers also promoted the transcription of pro-inflammatory cytokines and inhibited the transcription of anti-inflammatory cytokines.

*Rs28362491* polymorphism is located between two putative key promoter regulatory elements of *NF-κB1* gene. This polymorphic site consists of three genotypes, namely mutant homozygous DD (deletion/deletion), heterozygous DI (deletion/insertion), and wild homozygous II (insertion/insertion) \[[@CR36]\]. Park et al. found that individuals with DD homozygous genotype have lower activated NF-κB \[[@CR37]\]. Additionally, compared with II homozygous endothelial cells, DD homozygous cells appeared to have a lower increase in eNOS protein level under unidirectional laminar shear stress \[[@CR37]\]. Fontaine-Bisson et al. \[[@CR38]\] observed that D allele of *rs28362491* was associated with higher level of C-reactive protein, which was an established risk indicator for cardiovascular disease. The in vitro study revealed that the D allele in *rs28362491* polymorphism might result in reduced *NF-κB1* message, thus decreasing the expression of NF-κB1 \[[@CR39]\]. The NF-κB1 appears to be specifically involved in anti-inflammatory effects, and decreased NF-κB1 can promote the transcription of pro-inflammatory cytokines like TNF-α and IL-12 \[[@CR40]\], which are contributors of CAD \[[@CR41], [@CR42]\].

The findings of this study could contribute to a broader recognition of the genetic architecture of CAD. In the near future, with the enhanced understanding of genetics, evidence from the genetic studies may have the capacity to improve healthcare of an individual with CAD by taking preventive measures, offering accurate diagnosis, as well as providing personalized treatment. Additionally, appropriate screening programs can be carried out for an individual with a first-degree relative has a history of CAD. Genetic studies may serve to recognize genes as potential therapeutic targets.

It was noted that Chen et al. \[[@CR43]\] had published a similar meta-analysis in 2014. Nevertheless, the current study has notable advantages. First, several newly published papers \[[@CR18]--[@CR22], [@CR24], [@CR25]\] were included in our study, and the number of included studies and participants were greatly enlarged. Second, a more comprehensive search strategy was employed to obtain relevant studies at a maximum. Third, we adopt a more strict inclusion and exclusion criteria, and excluded Lopez-Mejias et al.'s study \[[@CR44]\], of which cardiovascular disease was considered to be equal to CAD by Chen et al. \[[@CR43]\]. Fourth, sensitive analysis was conducted to check the stability of the outcomes. Consequently, these advantages strongly guaranteed a more accurate and reliable conclusion.

Inevitably, this study had several drawbacks. First, the effect sizes were based on unadjusted evaluation for lack of sufficient data, and failure to perform further adjusted analyses might influence the reliability of those findings. Second, like most disease, CAD is a multi-factorial disorder that is associated with genetic and environmental factors. Nevertheless, owing to lack of detailed data in primary studies, we were unable to evaluate the effects of multi-factor interactions. Third, the included populations were from Asian and Caucasian populations, ethnicity bias might exist in our analysis. Thus, the findings might not be applicable to other populations. Last, only three English databases and two Chinese databases were retrieved for potentially relevant studies, although no obvious dissymmetry in any funnel plot was observed, publication biases might exist which could influence the results.

Conclusion {#Sec15}
==========

The current study indicates that the mutant D allele in *rs28362491* locus may increase the risk of CAD, and carriers of D allele appear to be more susceptible to CAD. Due to limitations of this study, the association between *rs28362491* polymorphism and CAD could not be entirely concluded. Further well-designed studies among different ethnicities are still warranted to confirm our findings.
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